Turkish Journal of Nephrology
Original Article

Effect of Atorvastatin Therapy on IL-6, IL-10, TNF-∝ and TGF-β in Chronic Hemodialysis Patients

1.

Haydarpaşa Numune Eğitim ve Araştırma Hastanesi, Dahiliye Servisi, İstanbul, Türkiye

2.

Fresenius Diamed Diyaliz Merkeziİstanbul, Türkiye

3.

Haydarpaşa Numune Eğitim ve Araştırma Hastanesi, İmmünoloji Ünitesi, İstanbul, Türkiye

4.

Haydarpaşa Numune Eğitim ve Araştırma Hastanesi, Transplantasyon Ünitesi, İstanbul, Türkiye

Turkish J Nephrol 2010; 19: 88-93
DOI: 10.5262/tndt.2010.1002.63
Read: 1200 Downloads: 691 Published: 12 February 2019

OBJECTIVE: We aimed to compare serum cytokine levels of IL- 6, IL-10, TNF-α and TGF-β before
and after atorvastatin therapy in chronic hemodialysis (HD) patients in order to detect infl ammatory and
anti-infl ammatory effects of atorvastatin in this study.
 

MATERIAL and METHODS: Thirty-one patients (19 male, 12 female) undergoing continuous
hemodialysis with a mean age 48.5+12.8 and dialysis age 12+4.3 years were included in our study.
HD was planned as 3 days a week with Fresenius 4008-B during 4 hours, FX80 with Kt/V >1.4. We
measured the serum cytokine levels of the patients with the ELISA technique, before atorvastatin
therapy and after 40 mg/day atorvastatin administration during 8 weeks.
 

RESULTS: Hemodialysis leads to a statistically signifi cant increase in proinfl ammatory cytokines (IL6 and TNF-α) and antiinfl ammatory cytokines (IL-10 ve TGF-β). However, atorvastatin therapy acts to
increase IL-6 and IL-10 only due to hemodialysis.

CONCLUSION: Atorvastatin therapy suppressed the increase in TNF-α and TGF-β due to hemodialysis. Suppression of TNF-α, an important
proinfl ammatory cytokine, is a valuable result to emphasize the anti-infl ammatory effect of atorvastatin.

Files
EISSN 2667-4440